Stop blaming the global supply chain for the empty pharmacy shelves in Tunis.
The narrative being pushed by international observers and local activists is lazy. They point to "medication shortages" as a generic symptom of economic decay, a byproduct of a flailing central bank, or a simple logistics failure. This perspective is not just wrong; it is dangerous. It masks the reality that the disappearance of emergency contraception—the "morning-after pill"—is a calculated result of a decaying public health philosophy that has traded reproductive autonomy for bureaucratic survival. In related news, we also covered: The Unlikely Truce Inside the Halls of Public Health.
I have spent years watching health ministries in the MENA region navigate currency devaluations. When a country runs out of heart medication, it’s a tragedy of math. When a country runs out of the morning-after pill while luxury skincare remains stocked in the private sector, it’s a tragedy of intent.
The Myth of the Unobtainable Pill
The common refrain is that the Pharmacie Centrale de Tunisie (PCT) can no longer afford to import these drugs. On the surface, the numbers look grim. The PCT’s debt to foreign laboratories is astronomical. But look closer at what is available. Mayo Clinic has analyzed this fascinating subject in great detail.
If the crisis were purely financial, the shortage would be uniform across all hormonal treatments. It isn’t. We are seeing a selective evaporation of specific reproductive health tools. Levonorgestrel is not a complex, patented biological drug that costs thousands of dollars per dose. It is a cheap, off-patent chemical. The failure to secure it isn't an "affordability" issue; it’s a procurement prioritization failure.
Tunisia was once the regional gold standard for family planning. The 1960s and 70s saw a state-led push for reproductive rights that outpaced many European nations. Today, that legacy is being dismantled not by a decree, but by a thousand bureaucratic cuts. When you centralize 100% of drug imports through a single, debt-ridden state entity, you create a choke point. If that entity decides—or is "encouraged"—to prioritize life-saving chronic meds over "lifestyle" or "preventative" pills, the latter vanish.
The Private Sector Parasite
While activists cry out about the "shortage," the black market and the gray market are thriving.
Go to a high-end pharmacy in Marsa or Gammarth. If you have the right connections or the right amount of cash, the "unobtainable" becomes accessible. This creates a two-tier system of biological citizenship. The wealthy buy their way out of the state’s failure. The working class in rural governorates is left with "availability" on paper and empty boxes in reality.
We need to stop asking "Where are the pills?" and start asking "Who benefits from the shortage?"
The shortage serves as a convenient tool for a conservative shift in social policy. By making emergency contraception hard to find, the state reasserts control over the bodies of its citizens without ever having to pass a single unpopular law. It’s "regulation by neglect." If you can't buy the pill, you don't have the choice.
The Failure of the "Human Rights" Framing
NGOs love to frame this as a violation of human rights. They are right, but they are ineffective.
Protesting for "rights" in a country facing a sovereign debt crisis is like screaming at a hurricane. The ministry will simply shrug and point to the balance sheet. To fix this, we have to stop talking about rights and start talking about market liberalization and decentralization.
The PCT’s monopoly is the poison.
If the Tunisian government actually cared about women’s health, it would allow private distributors to import emergency contraception directly. By bypassing the bottleneck of the state-run central pharmacy, the price might fluctuate, but the product would exist.
The counter-argument is always: "But the state must subsidize these drugs to keep them affordable for the poor."
This is the ultimate lie. A subsidized pill that doesn’t exist is infinitely more expensive than a market-priced pill that does. When the state claims a monopoly on a "subsidized" good it cannot deliver, it isn't protecting the poor; it is sentencing them to forced pregnancies and back-alley solutions.
The Data the Ministry Ignores
Let’s look at the "hidden" costs of this shortage.
- Increased Maternal Mortality: Desperate people do desperate things. When contraception fails and the morning-after pill is gone, the next step isn't "acceptance." It’s the informal market for Misoprostol or dangerous physical interventions.
- Economic Displacement: A single unplanned pregnancy for a woman in a precarious job in Sfax or Kasserine can end her participation in the workforce permanently.
- The Brain Drain: Young medical professionals are leaving Tunisia in droves. They aren't just leaving for better salaries; they are leaving because they are tired of being frontline soldiers in a system where they have to tell crying patients "no" every single day.
Imagine a scenario where a pharmacist has to choose between stocking insulin for a diabetic regular and a ten-pack of emergency contraceptives. Under the current PCT rationing, the choice is forced. The system is designed to pit different health needs against each other to mask the fact that the total pot is shrinking.
Stop Asking the Wrong Question
The media keeps asking: "When will the shipments arrive?"
That is the wrong question. Even if a shipment arrives tomorrow, the underlying structure ensures it will run out again in three months. The supply chain is a symptom. The disease is a centralized, state-controlled medical economy that uses "shortages" as a shield against accountability.
We have to demand the end of the PCT monopoly on non-essential medications. We have to demand that reproductive health be treated as a critical infrastructure, not a luxury line item that can be deleted when the IMF comes knocking.
The "disappearance" of the pill in Tunisia isn't a mystery. It’s a policy. If you want to find the pills, you don't look in the warehouses; you look at the desks of the men who decided that a woman's emergency isn't a national priority.
The legacy of Bourguiba is being sold for parts, and the first thing to go was the autonomy of half the population. This isn't a pharmacy problem. It's a power problem.
Open the markets or admit you’ve abandoned the citizens you claim to protect.
